TL;DR
This study identifies five new genetic regions associated with open-angle glaucoma (OAG) by combining genome-wide association study (GWAS) data from OAG with related eye traits like intraocular pressure (IOP) and optic disc parameters. This integrative approach, a first of its kind for OAG, not only increases the power to detect genetic risk factors but also reveals potential links between OAG and other eye conditions like myopia and age-related macular degeneration.
What Problem Does This Paper Address?
Open-angle glaucoma (OAG) is a leading cause of irreversible blindness globally, characterized by optic nerve damage and vision loss. While its genetic component is significant, previous genome-wide association studies (GWAS) have only explained a fraction of the heritability, leaving many risk loci undiscovered. This gap hinders the development of accurate genetic risk prediction tools and targeted therapeutic strategies. The challenge lies in the complex genetic architecture of OAG, where multiple genes with small effects contribute to disease risk. To overcome this, researchers are exploring the use of "endophenotypes" – measurable traits that are genetically correlated with the disease, such as intraocular pressure (IOP) and optic disc parameters (cup area, disc area, vertical cup-to-disc ratio). These endophenotypes are thought to share genetic underpinnings with OAG, and combining GWAS data from both OAG and its endophenotypes could boost statistical power to identify novel risk variants.
Methods
The study employed a multi-pronged approach to identify new OAG risk loci:
- Meta-analysis of GWAS data: The core of the study involved combining GWAS data from OAG cases and controls with existing GWAS data for OAG endophenotypes (IOP, optic disc parameters). This was done using a fixed-effects meta-analysis to increase statistical power.
- Single Variant Tests: Standard GWAS analysis was performed to identify individual genetic variants (SNPs) associated with OAG.
- Gene-Based Tests: This approach looks for associations at the gene level, considering all variants within a gene. The study utilized three different gene-based testing frameworks (MetaXcan, fastBAT, EUGENE) to leverage different assumptions and data types.
- Pathway-Based Tests: This method investigates whether specific biological pathways are enriched for genetic associations with OAG. The DEPICT tool was used for this analysis.
- Replication: Identified novel loci were independently validated in a separate dataset (NEIGHBORHOOD) to confirm their association with OAG.
- Gene Expression Analysis: The expression levels of genes near the identified risk loci were examined in relevant ocular tissues to understand their potential functional roles.
Datasets
- Discovery Dataset:
- 3,071 OAG cases and 6,750 unscreened controls of European descent from the Australian & New Zealand Registry of Advanced Glaucoma (ANZRAG).
- GWAS data for OAG endophenotypes (intraocular pressure, optic disc parameters) from previous studies, with sample sizes varying between 32,000 to 48,000 participants for the overall meta-analysis.
- Replication Dataset:
- The NEIGHBORHOOD consortium dataset, comprising 3,853 OAG cases and 33,480 controls.
Key Insights and Ideas
- The Power of Integration: The study strongly demonstrates that combining GWAS data from a disease (OAG) with its genetically correlated endophenotypes (IOP, optic disc parameters) significantly enhances the power to discover novel genetic risk loci. This is a crucial methodological advancement for complex trait genetics.
- Beyond Single Variants: While single variant analysis is standard, the inclusion of gene-based and pathway-based approaches provided complementary insights, identifying a new risk locus (C9) and biological pathways ("response to fluid shear stress," "abnormal retina morphology") implicated in OAG.
- Pleiotropy in Eye Disease: The identified OAG risk loci show interesting overlap with genetic risk factors for other eye conditions like myopia and age-related macular degeneration (AMD). This suggests shared genetic pathways and a potential common biological basis for these seemingly distinct eye diseases.
- Functional Clues from Gene Expression: Examining gene expression in ocular tissues provided valuable context, showing that genes near the identified risk loci (e.g., LMX1B, MYOF, LMO7) are expressed in relevant ocular structures like the trabecular meshwork and cornea, hinting at their functional roles in OAG pathogenesis.
Key Results
- Five New Risk Loci Identified: The study identified four novel genome-wide significant associations through single variant tests and one additional locus (C9) via gene-based tests. These loci are located near genes such as MYOF, CYP26A1, LINC02052, CRYGS, LMX1B, and LMO7.
- Two Novel Pathways: Two genetic pathways, "response to fluid shear stress" and "abnormal retina morphology," were significantly associated with OAG.
- Replication Success: Four of the identified loci were independently validated in the NEIGHBORHOOD dataset, strengthening their association with OAG.
- Links to Other Eye Diseases: Some of the new risk loci were also found to contribute to the risk of myopia and age-related macular degeneration, highlighting pleiotropy.
- Gene Expression Patterns: Genes near the identified loci, such as LMX1B and MYOF, showed higher expression in ocular tissues relevant to glaucoma, such as the trabecular meshwork.
Limitations and Future Work
- Data Availability: The datasets generated in this study are not publicly available due to ethical considerations.
- Meta-analysis Approach: The authors acknowledge that they did not use newer, more sophisticated meta-analysis approaches for correlated traits that account for overlapping subjects and heterogeneity. However, they performed sensitivity analyses and LD score regression to mitigate potential biases.
- Separate Endophenotype Analysis: The study analyzed OAG in combination with each endophenotype separately, rather than a multi-trait meta-analysis. This was justified by the distinct pathways of IOP and optic disc morphology and potential subject overlap.
- Future Directions: The authors emphasize the need for fine-mapping and functional validation of the newly identified risk loci to fully understand disease pathophysiology. They also suggest that larger sample sizes in future studies will be crucial for more accurate genetic risk prediction algorithms and the identification of new therapeutic targets for OAG. The findings also open avenues for exploring the shared genetic underpinnings of various eye diseases.
Summary updated